- Home
- EDSA vs LAES Comparison
EDSA vs LAES Comparison
Compare EDSA & LAES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- LAES
- Stock Information
- Founded
- EDSA 2015
- LAES 2022
- Country
- EDSA Canada
- LAES Switzerland
- Employees
- EDSA N/A
- LAES N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- LAES Semiconductors
- Sector
- EDSA Health Care
- LAES Technology
- Exchange
- EDSA Nasdaq
- LAES Nasdaq
- Market Cap
- EDSA 13.8M
- LAES 453.6M
- IPO Year
- EDSA N/A
- LAES N/A
- Fundamental
- Price
- EDSA $2.18
- LAES $3.36
- Analyst Decision
- EDSA Strong Buy
- LAES Strong Buy
- Analyst Count
- EDSA 2
- LAES 1
- Target Price
- EDSA $13.00
- LAES $6.00
- AVG Volume (30 Days)
- EDSA 22.9K
- LAES 10.7M
- Earning Date
- EDSA 08-08-2025
- LAES 07-22-2025
- Dividend Yield
- EDSA N/A
- LAES N/A
- EPS Growth
- EDSA N/A
- LAES N/A
- EPS
- EDSA N/A
- LAES N/A
- Revenue
- EDSA N/A
- LAES $10,981,000.00
- Revenue This Year
- EDSA N/A
- LAES N/A
- Revenue Next Year
- EDSA N/A
- LAES N/A
- P/E Ratio
- EDSA N/A
- LAES N/A
- Revenue Growth
- EDSA N/A
- LAES N/A
- 52 Week Low
- EDSA $1.55
- LAES $0.29
- 52 Week High
- EDSA $5.59
- LAES $11.00
- Technical
- Relative Strength Index (RSI)
- EDSA 60.86
- LAES 41.35
- Support Level
- EDSA $1.89
- LAES $3.31
- Resistance Level
- EDSA $2.23
- LAES $4.28
- Average True Range (ATR)
- EDSA 0.11
- LAES 0.30
- MACD
- EDSA 0.02
- LAES -0.11
- Stochastic Oscillator
- EDSA 85.29
- LAES 3.77
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.